Načítá se...
Clinical use of the β(3) adrenoceptor agonist mirabegron in patients with overactive bladder syndrome
Mirabegron is a β(3) adrenoceptor agonist licensed for the treatment of overactive bladder symptoms, such as urinary urgency or urgency incontinence. β(3) adrenoceptor activation causes detrusor muscle relaxation, but mirabegron may also act by binding other targets in the bladder, and it may also r...
Uloženo v:
| Vydáno v: | Ther Adv Urol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4549701/ https://ncbi.nlm.nih.gov/pubmed/26425139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215591763 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|